Assessing the efficacy and safety of magnesium sulfate for management of autonomic nervous system dysregulation in Vietnamese children with severe hand foot and mouth disease.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Brainstem encephalitis is a serious complication of hand foot and mouth disease (HFMD) in children.

Vietnamese national guidelines recommend use of milrinone if ANS dysregulation with Stage 2 hypertension develops.

Who Took Part

By PubMed's age tags, the people studied were infants, young children and children, both men and women.

During a regional epidemic the researchers conducted a randomized, double-blind, placebo-controlled trial of MgSO4 in children with HFMD, ANS dysregulation and Stage 1 hypertension, at the Hospital for Tropical Diseases in Ho Chi Minh city.

Study participants received an infusion of MgSO4 or matched placebo for 72 h.

How the Study Was Run

The researchers set it up as a randomized, double-blind and placebo-controlled study.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

Neither the participants nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.

The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.

The researchers also reviewed data from non-trial HFMD patients in whom milrinone failed to control hypertension, some of whom received MgSO4 as second line therapy.

What Was Measured

PubMed files the paper under topics including Autonomic Nervous System, Autonomic Nervous System Diseases, Cohort Studies, Disease Progression, Hand, Foot and Mouth Disease, Hemodynamics and Magnesium Sulfate.

Author keywords: Autonomic nervous system dysregulation, Brainstem encephalitis, Clinical trial, Hand foot and mouth disease and Hypertension.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2019 (BMC infectious diseases), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.